Home | Register | Login | Inquiries | Alerts | Sitemap |  


Advanced Search
JKM > Volume 47(2); 2026 > Article
Bang, Shin, Kim, Kang, Lee, Kim, Kim, Son, Jeon, and Kang: Weight Loss Goals and Lifestyle Characteristics of Mongolian Participants in Korean Medicine-Based Weight Management Consultation: An Exploratory Cross-Sectional Survey

Abstract

Objectives

Mongolia has experienced a rapid nutrition transition accompanied by increasing obesity prevalence. This study aimed to describe weight loss goals, lifestyle characteristics, and health-related features among Mongolian participants who voluntarily attended a Korean Medicine (KM)-based weight management consultation event.

Methods

This exploratory cross-sectional study was conducted among Mongolian participants who voluntarily attended a KM-based weight management consultation event in Ulaanbaatar. Data collected included demographic characteristics, body mass index (BMI), desired and physician-recommended weight loss, food preferences, eating patterns, sleep patterns, alcohol preferences, and general health conditions.

Results

Forty participants (95% female; mean age 42.5 years) were enrolled, and most were overweight or obese. On average, participants desired a weight reduction of 14.2±8.9 kg (17.9±7.5%), which was slightly higher than the mean physician-recommended target. In self-reported responses, participants frequently selected red meat and refined grains as preferred foods, whereas fruit and vegetable preferences were less frequently selected. Sleep-related problems were self-reported by 72.5% of participants. Beer was the most frequently preferred alcoholic beverage, and social media was the primary referral pathway (72.5%).

Conclusions

This exploratory cross-sectional survey provides preliminary descriptive data on weight loss goals, lifestyle characteristics, health-related features, and referral pathways among Mongolian participants in a KM-based weight management consultation event. These findings should be interpreted as preliminary self-reported responses from a non-validated pre-consultation questionnaire and may inform culturally tailored pre-treatment counseling programs and future intervention studies.

Fig. 1
Flow of participant attendance
jkm-47-2-203f1.gif
Fig. 2
Referral pathway of participants
jkm-47-2-203f2.gif
Fig. 3
BMI classification of participants (Based on WHO criteria): Normal (BMI 18.5–24.9); Overweight (BMI 25.0–29.9); Obesity Class 1 (BMI 30.0–34.9); Obesity Class 2 (BMI 35.0–39.9). BMI: body mass index.
jkm-47-2-203f3.gif
Table 1
Baseline Characteristics of Participants (n=40)
Characteristics Participants, n (%)
Gender Female 38 (95), Male 2 (5)
Age (years) 42.53±11.49
Marital Status Married 36 (90), Single 4 (10)
Parity (n=33)* 2.24±1.71 (range: 0–7)
Job Service Industry 9 (22.5), Homemakers 8 (20), Office Workers 7 (17.5), Professionals 6 (15) (Accountants 3, Pharmacist 1, Pediatrician 1, Real Estate Agent 1), Unknown 4 (10), Retired, Students 2 (5), Researcher, Entrepreneur 1 (2.5)

* Among the total of 40 participants, 5 with unspecified details and 2 males were excluded, resulting in a final count of 33.

Table 2
Body Weight and Weight Loss Targets of Participants (n=40)
Category Max BW (kg) Min BW (kg) Hope BW (kg) Current BW (kg) Target WL (Patient, kg) Target WL (Doctor, kg)
AVG±SD 82.05±12.41 55.78±9.12 59.53±7.70 73.7±12.17 14.18±8.90 13.71±7.32
Max 109 90 80 100.8 35.7 35
Min 58 43 45 53.3 0.9 4

BW: Body weight, WL: weight loss, AVG: average, SD: Standard deviation, Max: Maximum, Min: Minimum.

Table 3
Body Composition Measurements from BIA (n=40)
Category Height (cm) Current SMM (kg) Current BFM (kg) Current BMI (kg/m2) Current %BF (%)
AVG±SD 161.36±6.30 24.9±3.95 28.0±7.99 28.0±4.52 38.0±5.82
Max 181 41.4 48 40 50
Min 150 18.6 17 22 28

BIA: Bioelectrical Impedance Analysis, SMM: Skeletal muscle mass, BFM: Body fat mass, BMI: Body mass index, %BF: Percent Body Fat, AVG: average, SD: Standard deviation, Max: Maximum, Min: Minimum.

Table 4
Past Diet History, Primary Weight Loss Goals, and Targeted Fat Loss Areas of Participants (n=40)
Category Responses, n (%)
Past diet history Exercise 20 (50), Fasting 14 (35), Monotrophic diet 11 (27.5), Detox diet 10 (25), Dietary supplement 8 (20), Conventional medicine 2 (5), Keto diet 1 (2.5), Liposuction 1 (2.5), Traditional medicine 1 (2.5)
Primary weight loss goals Constitution improvement 16 (40), Health promotion 14 (35), Short-term weight reduction 11 (27.5), Regional fat loss 9 (22.5)
Targeted fat loss areas Abdomen 29 (72.5), Arms 17 (42.5), Whole body 10 (25)*, Back 3 (7.5), Legs 3 (7.5)

Multiple selections were allowed.

* : The whole body and individual body parts cannot be selected simultaneously.

Table 5
Preferred Food Categories, Eating Habits, and Preferred Alcohol Types among Participants ( n=40)
Category Responses, n (%)
Preferred Food Categories Red meat 35 (87.5), Refined grains 23 (57.5), Whole grains 16 (40), Vegetables 16 (40), Fruits 14 (35), Fried foods 14 (35), All foods 2 (5)*, Others (nuts) 1 (2.5)
Eating Habits and Patterns Binge eating 16 (40), Small frequent meals 14 (35), Irregular meal patterns 14 (35), Overeating 6 (15), Snacking 4 (10)
Preferred Alcohol Types Beer 18 (45), Spirits (vodka, etc.) 10 (25), Wine 10 (25), Traditional fermented alcoholic beverage (Airag, etc.) 4 (10)

Multiple selections were allowed.

* : The all foods and individual food categories were not selected simultaneously.

Table 6
Self-Reported Symptoms, Current Medication Use, and Past Medical History among Participants (n=40)
Category Responses, n (%)
Self-reported symptoms Excessive sweating 18 (45), Constipation 17 (42.5), Numbness 15 (37.5), Cold hands and feet 10 (25), Indigestion 10 (25), Swelling 6 (15), Warm hands and feet 5 (12.5), Menopausal symptoms 4 (10), Headache 3 (7.5), No sweating 2 (5), Muscle cramps 2 (5), No symptoms 2 (5), Diarrhea 1 (2.5), Heartburn 1 (2.5)
Current medication use Not taking medication 21 (52.5), Hypertension medication 9 (22.5), Sleeping pills 3 (7.5), Antihistamines 3 (7.5), Laxatives 1 (2.5), Thyroid medication 1 (2.5), Gout medication 1 (2.5), Female hormone medication 1 (2.5), Liver medication 1 (2.5), Digestive medicine 1 (2.5), Anticoagulants 1 (2.5), No response 1 (2.5)*
Past medical history and present illness Allergy 12 (30), Hypertension 5 (12.5), Arrhythmia 5 (12.5), Fatty liver 5 (12.5), None 5 (12.5), Hepatitis carrier 4 (10), Diabetes 3 (7.5), Hair loss 2 (5), Cholecystectomy 2 (5), Gastroesophageal reflux disease 2 (5), Renal dysfunction 2 (5), Liver dysfunction 2 (5), Appendectomy 2 (5), Cesarean section 2 (5), Depression 2 (5), Deviated nasal septum 1 (2.5), Hip surgery 1 (2.5), Tonsillectomy 1 (2.5), Spinal disc surgery 1 (2.5), Cystitis 1 (2.5), Heart valve disease 1 (2.5)

Multiple responses were allowed.

* : The types of medications taken are numerous, so they have not been recorded.

Table 7
Sleep Patterns and Disturbances among Participants (n=40)
Category n (%)
Light Sleep 21 (52.5)
No Sleep Issues 11 (27.5)
Difficulty Falling Asleep 9 (22.5)
Caffeine Sensitivity 4 (10)
Frequent Dreaming 2 (5)
Night Shift 1 (2.5)
Sleeping Pills 1 (2.5)
Irregular Sleep Pattern 1 (2.5)

Multiple selections are allowed.

Table 8
Menstrual History and Status of Female Participants (n=38)
Category n (%)
Irregular Menstruation 11 (28.9)
Normal 11 (28.9)
Menopause 11 (28.9)
 Natural Menopause 10 (26.3)
 Hysterectomy-Induced Menopause 1 (2.6)
Menstrual Pain 10 (26.3)
No Response 6 (15.8)
Menopausal Symptoms 3 (7.9)
Temporary Suspension (Contraceptive Device Use) 1 (2.6)

Multiple selections were allowed.

참고문헌

1. Ministry of Government Legislation. (2016). Act on hospice and palliative care and decisions on life-sustaining treatment for patients at the end of life,


2. Kim, C. G. (2019). The history of hospice and palliative care in Korea. Korean J Hosp Palliat Care, 22(1), 1-7.
crossref

3. Kim, K. W., Kim, W. R., Nam, E. J., Kye, S. Y., & Choi, J. Y. (2025). The national hospice policy of the 2nd comprehensive hospice and life-sustaining treatment plan (2024–2028) in the Republic of Korea. Health Policy and Management J, 35(1), 16-25.


4. Ministry of Health and Welfare. (2019). The first comprehensive hospice and life-sustaining treatment plan (2019–2023). Sejong, Korea. Ministry of Health and Welfare.


5. National Hospice Center, National Cancer Center. Status of designated hospice institutions (2026) [Internet] Goyang: National Hospice Center. (2026). [cited 2026 Feb 12]. Available from: URL:https://hospice.go.kr:8444/?menuno=23


6. National Hospice Center & Ministry of Health and Welfare. (2024). Annual report on national hospice and palliative care (2024). Goyang, Korea. National Hospice Center.


7. World Health Organization. (2020). Global atlas of palliative care. Global atlas of palliative care. 2nd ed. London. Worldwide Palliative Care Alliance.


8. Ministry of Health and Welfare. (2024). The second comprehensive hospice and life-sustaining treatment plan (2024–2028). Sejong, Korea. Ministry of Health and Welfare.


9. Koh, J., Rhee, C. W., Han, H. S., Yoo, S. H., & Keam, B. (2024). A study on terminal cancer patients’ experiences regarding consultation-based hospice palliative care. Health and Social Welfare Review, 40(1), 298-324.


10. Li, J., He, J., Tang, Z., Jing, L., & Zhu, L. (2025). Palliative care in Shanghai communities: Needs, influencing factors and preferences among older adults with chronic diseases. Healthcare, 13(23), 3048.
crossref pmid pmc

11. Kwon, S., Kim, K., Park, B., Park, S. J., Jho, H. J., & Choi, J. Y. (2024). Decreased aggressive care at the end of life among advanced cancer patients in the Republic of Korea: A nationwide study from 2012 to 2018. BMC Palliative Care, 23(1), 160.
crossref pmid pmc pdf

12. Statistics Korea. Korean Statistical Information Service (KOSIS). Cancer registration statistics [Internet] Daejeon: Statistics Korea. [cited 2026 Feb 19]. Available from: URL:https://kosis.kr


13. Statistics Korea. (2025). Causes of death statistics in 2024. Daejeon. Statistics Korea.


14. Mizrahi, J. D., Surana, R., Valle, J. W., & Shroff, R. T. (2020). Pancreatic cancer. The Lancet, 395(10242), 2008-2020.
crossref pmid pmc

15. Roa, J. C., Garcia, P., Kapoor, V. K., Maithel, S. K., Javle, M., & Koshiol, J. (2022). Gallbladder cancer. Nature Reviews Disease Primers, 8(1), 69.
crossref pmid pmc pdf

16. Lee, G. J., Ahn, H. S., Go, S. E., Kim, J. H., Seo, M. W., & Kang, S. H., et al (2015). Patient’s factors at entering hospice affecting length of survival in a hospice center. Cancer Research and Treatment: Official Journal of Korean Cancer Association, 47(1), 1-8.
crossref pmid pmc pdf

17. Thompson, E., Sanchez Pellecer, D., Hanson, G. J., Inselman, S. A., Manggaard, J. M., & Whitford, K. J., et al (2025). Patient, provider, and health system determinants of hospice length of stay. Palliat Med Rep, 6(1), 144-152.
crossref pmid pmc pdf

18. Hui, D., Kim, S. H., Kwon, J. H., Tanco, K. C., Zhang, T., & Kang, J. H., et al (2012). Access to palliative care among patients treated at a comprehensive cancer center. The Oncologist, 17(12), 1574-1580.
crossref pmid pmc pdf

19. Yun, S. J., Gwak, J. I., Choi, H. J., Shin, J. S., Nam, J. W., & An, H. J. (2016). The characteristics of terminally ill cancer patients who expired within 72 hours after admission to a hospice. Korean J Farm Pract, 6(3), 160-165.
crossref

20. Sedhom, R., Blackford, A. L., Gupta, A., Griffiths, K., Heussner, J., & Carducci, M. A. (2021). End-of-life characteristics associated with short hospice length of stay for patients with solid tumors enrolled in phase I clinical trials. Journal of the National Comprehensive Cancer Network, 19(6), 686-692.
crossref pmid pmc

21. Ernecoff, N. C., Wessell, K. L., Hanson, L. C., Dusetzina, S. B., Shea, C. M., & Weinberger, M., et al (2020). Elements of palliative care in the last 6 months of life: Frequency, predictors, and timing. J Gen Intern Med, 35(3), 753-761.
crossref pmid pmc pdf

22. Chang, H. C., Lai, Y. H., Lin, K. C., Lee, T. Y., & Lin, H. R. (2017). Evaluation of pain intensity assessment tools among elderly patients with cancer in Taiwan. Cancer Nursing, 40(4), 269-275.
crossref pmid

23. Thong, I. S., Jensen, M. P., Mir, J., & Tan, G. (2018). The validity of pain intensity measures: What do the NRS, VAS, VRS, and FPS-R meas ure? Scandinavian Journal of Pain, 18(1), 99-107.
crossref pmid

24. Azam, F., Latif, M. F., Farooq, A., Tirmazy, S. H., AlShahrani, S., & Bashir, S., et al (2020). Performance status assessment by using ECOG (Eastern cooperative oncology group) score for cancer patients by oncology healthcare professionals. Case Reports in Oncology, 12(3), 728-736.
crossref pmid pmc pdf

25. Brecher, D. B., & Sabol, H. J. (2024). Prognos tication in hospice care: Challenges, opportunities, and the importance of functional status. Federal Practitioner, 41(Suppl 3), S50-S53.
crossref pmid pmc

26. Clark, J., Raijmakers, N. J., Allan, S., Zuylen, L. V., & Heide, A. V. D. (2017). Declining oral intake towards the end of life: how to talk about it? A qualitative study. International Journal of Palliative Nursing, 23(2), 74-82.
crossref pmid

27. Chang, Y. J. (2017). Understanding of changes to hospice & palliative care brought by the enforcement of the act on hospice & palliative care and dying patient determination of life sustaining treatments. Korean J Hosp Palliat Care, 20(3), 173-176.
crossref pdf

28. Kim, G. L., Lee, S. H., Kim, Y. J., Lee, J. G., Yi, Y. H., & Tak, Y. J., et al (2023). Utilization of end-of-life care rooms by patients who died in a single hospice unit at a national university hospital in South Korea. J Hosp Palliat Care, 26(2), 60-68.
crossref pmid pmc

29. Yun, Y. H., Rhee, Y. S., Nm, S. Y., Chae, Y. M., Heo, D. S., & Lee, S. W., et al (2004). Public attitudes toward dying with dignity and hospice · palliative care. J Hosp Palliat Care, 7(1), 17-28.


30. van de Glind, I., van Dulmen, S., & Gooss ens en, A. (2008). Physician-patient communication in single-bedded versus four-bedded hospital rooms. Patient Education and Counseling, 73(2), 215-219.
crossref pmid

31. Yoon, H. C., Son, C. G., Lee, N. H., & Cho, J. H. (2018). Study on the development history on hospice · palliative care and need for Korean medicine. J Int Korean Med, 39(4), 662-675.
crossref pdf

32. Choi, J. W., Nam, Y. K., Lee, H. J., & Woo, H. J. (2021). Review of clinical study over the last 10 year s on Korean medicine treatment for cancer: Focusing on Korean database. J Korean Med Rehabil, 31(4), 75-86.
crossref

33. Yang, J., Wahner-Roedler, D. L., Zhou, X., Johnson, L. A., Do, A., & Pachman, D. R., et al (2021). Acupuncture for palliative cancer pain management: Systematic review. BMJ Supportive & Palliative Care, 11(3), 264-270.
crossref pmid pmc

34. Kim, K. J., Shin, S. J., Kwon, I., Nam, E. M., Heo, D. S., & Lee, S. N. (2017). The necessity for end-of-life care education: a preliminary analysis with interns at two university hospitals. Korean J Hosp Palliat Care, 20(2), 111-121.
crossref pdf

35. Yang, K. H., & Kwon, S. I. (2015). The effects of attitude to death in the hospice and palliative professionals on their terminal care stress. Korean J Hosp Palliat Care, 18(4), 285-293.
crossref

TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
PubReader  PubReader
Download Citation  Download Citation
  Print
Share:      
METRICS
0
Crossref
1,288
View
33
Download
Editorial office contact information
3F, #26-27 Gayang-dong, Gangseo-gu Seoul, 157-200 Seoul, Korea
The Society of Korean Medicine
Tel : +82-2-2658-3627   Fax : +82-2-2658-3631   E-mail : skom1953@skom.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Developed in M2PI